Mr. Ben Ami is a seasoned executive with a successful track record of more than 20 years of in the biotech industry. He previously held a range of executive positions, including Head of the Eastern European and Israel region at Merck (MSD), Managing Director of the Merck subsidiary in Israel, and General Manager of Lundbeck Israel. Mr. Ben Ami is the founder of Triticum, a startup company that is developing a clot retriever device for the treatment of stroke and occlusions in peripheral vessels. He also acts as a consultant to pharma and medical device companies. Mr. ben Ami holds a Master of Health Systems Administration degree (M.H.A.) from Tel Aviv University, Israel.